Evidence map›Paper›PMID 35729732›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2022

Non-invasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM-OCT imaging device: a case-series.

A S Bang, J Monnier, U Harris, J Garfinkel, G Rubinstein, N Iftimia, M Pulitzer, M Murray, M E Lacouture, M Jain

Open access · greenAbstract read
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

A S BangDermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0002-1700-2411
J MonnierDermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
U HarrisDermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
J GarfinkelDermatology and Laser Centre, Studio City, California, USA.ORCID https://orcid.org/0000-0002-3925-7554
G RubinsteinDermatology and Laser Centre, Studio City, California, USA.
N IftimiaPhysical Sciences Inc, Andover, Massachusetts, USA.
M PulitzerDermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
M MurrayDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
M E LacoutureDermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0002-4818-3710
M JainDermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0002-6035-0825
Memorial Sloan Kettering Cancer Center · USCenter for Dermatology and Laser Surgery · USAndover Eye Associates · USCentre National de la Recherche Scientifique · FR

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundCutaneous metastases (CM) diagnosis is clinically challenging, requiring an invasive biopsy for confirmation. A novel, RCM-OCT device combines the advantage of horizontal high-resolution reflectance confocal microscopy (RCM) images and vertical deeper optical coherence tomography (OCT) images to aid in non-invasive diagnosis of CM from breast cancers.

objectiveCharacterize CM from breast cancers using RCM-OCT device.

methodsSeven patients suffering from breast cancers with suspicious CM were consented and imaged with RCM-OCT device. CM features were defined by comparing with histopathology. Tumour depths were measured on OCT and on H&E-images and correlated using statistical analysis Pearson test. 3D-OCT images were reconstructed to enhance tumour visualization.

results6/7 lesions were CM from breast cancers, and one was vascular ectasia, on histopathology. CM appeared as greyish-darkish oval to round structures within the dermis on RCM and OCT-images. On RCM, individual tumour cells were seen, enabling identification of even small tumour foci; while, on OCT deeper tumours were detected. Inflammatory cells, dilated vessels and coarse collagen were identified in the dermis. Pearson correlation had an r LIMITATION: Small sample size and lack of clinical mimickers.

conclusionRCM-OCT can detect CM and has potential in aiding non-invasive diagnosis and management.

Indexed as

Skin NeoplasmsTomography, Optical CoherenceBiopsyHumansMicroscopy, ConfocalSkin

Identifiers

PMID35729732
PMCPMC10337777
OpenAlexW4283323822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.